谷歌浏览器插件
订阅小程序
在清言上使用

A Phase 2 Double-Blind Placebo-Controlled 24-Week Treatment Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Mild Alzheimer's Disease

Brain Research Center, Metis Cognition Ltd.,Chu Hui-May,Blackburn Kelly,Alam John J.

Alzheimer s Research & Therapy(2021)

引用 37|浏览18
暂无评分
关键词
p38 MAPK,Alzheimer's,Episodic memory,Clinical trial,CSF biomarkers,Synaptic dysfunction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要